Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-05-16 Purchase |
2025-05-19 4:54 pm |
Jade Biosciences Inc. | JBIO | Frohlich Tom Chief Executive Officer |
6,000 | $7.4 | $44,400 | 6,000 (Direct) |
View |
| 2024-06-17 Purchase |
2024-06-20 5:56 pm |
Aerovate Therapeutics Inc. | AVTE | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner |
928,110 | $1.67 | $1,549,944 | 9,192,092 (Indirect) |
View |
| 2024-06-14 Sale |
2024-06-14 6:00 pm |
Aerovate Therapeutics Inc. | AVTE | Eldridge George A SEE REMARKS |
15,000 | $25.03 | $375,450 | 33,785 (Direct) |
View |
| 2024-06-14 Sale |
2024-06-14 6:00 pm |
Aerovate Therapeutics Inc. | AVTE | Verwijs Marinus CHIEF TECHNICAL OFFICER |
10,600 | $25 | $265,000 | 68,800 (Direct) |
View |
| 2024-06-13 Sale |
2024-06-14 6:00 pm |
Aerovate Therapeutics Inc. | AVTE | Gillies Hunter CHIEF MEDICAL OFFICER |
6,000 | $24.5 | $147,000 | 89,112 (Direct) |
View |
| 2024-05-17 Sale |
2024-05-17 7:10 pm |
Aerovate Therapeutics Inc. | AVTE | Gillies Hunter CHIEF MEDICAL OFFICER |
4,000 | $21.08 | $84,332 | 16,926 (Direct) |
View |
| 2024-05-16 Sale |
2024-05-17 7:10 pm |
Aerovate Therapeutics Inc. | AVTE | NOYES TIMOTHY P CHIEF EXECUTIVE OFFICER |
10,000 | $21.58 | $215,755 | 343,381 (Direct) |
View |
| 2024-05-02 Sale |
2024-05-03 6:00 pm |
Aerovate Therapeutics Inc. | AVTE | Verwijs Marinus CHIEF TECHNICAL OFFICER |
1,981 | $21.02 | $41,631 | 0 (Direct) |
View |
| 2024-05-01 Sale |
2024-05-03 6:00 pm |
Aerovate Therapeutics Inc. | AVTE | NOYES TIMOTHY P CHIEF EXECUTIVE OFFICER |
11,357 | $20.34 | $230,946 | 353,381 (Direct) |
View |
| 2024-04-17 Sale |
2024-04-19 6:00 pm |
Aerovate Therapeutics Inc. | AVTE | Dake Benjamin T SEE REMARKS |
6,853 | $22.37 | $153,327 | 97,227 (Direct) |
View |
| 2024-04-17 Sale |
2024-04-19 6:00 pm |
Aerovate Therapeutics Inc. | AVTE | Gillies Hunter CHIEF MEDICAL OFFICER |
4,000 | $22.38 | $89,522 | 6,301 (Direct) |
View |
| 2024-04-16 Sale |
2024-04-18 6:00 pm |
Aerovate Therapeutics Inc. | AVTE | NOYES TIMOTHY P CHIEF EXECUTIVE OFFICER |
10,000 | $24.7 | $246,971 | 363,381 (Direct) |
View |
| 2024-04-10 Sale |
2024-04-12 6:00 pm |
Aerovate Therapeutics Inc. | AVTE | Eldridge George A SEE REMARKS |
7,500 | $26.85 | $201,392 | 45,723 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-07-14 Option Award |
2025-07-14 7:12 pm |
N/A 2035-07-14 |
Jade Biosciences Inc. | JBIO | Dahms Bradford D. Chief Financial Officer |
526,000 | $0 | 526,000 (Direct) |
View |
| 2025-04-29 Option Award |
2025-05-01 6:16 pm |
N/A 2035-04-29 |
Jade Biosciences Inc. | JBIO | Fairmount Funds Management LLC Fairmount Healthcare Fund II L.P. Kiselak Tomas Harwin Peter Evan Director 10% Owner |
23,017 | $0 | 23,017 (Direct) |
View |
| 2025-04-29 Option Award |
2025-05-01 6:15 pm |
N/A 2035-04-29 |
Jade Biosciences Inc. | JBIO | Lavelle Erin Director |
23,017 | $0 | 23,017 (Direct) |
View |
| 2025-04-29 Option Award |
2025-05-01 6:10 pm |
N/A 2035-04-29 |
Jade Biosciences Inc. | JBIO | Klein Lawrence Otto Director |
23,017 | $0 | 23,017 (Direct) |
View |
| 2025-04-29 Option Award |
2025-05-01 6:07 pm |
N/A 2035-04-29 |
Jade Biosciences Inc. | JBIO | CAIN CHRISTOPHER W. Director |
23,017 | $0 | 23,017 (Direct) |
View |
| 2025-04-29 Option Award |
2025-05-01 6:00 pm |
N/A 2035-04-29 |
Jade Biosciences Inc. | JBIO | DOBMEIER ERIC Director |
23,017 | $0 | 23,017 (Direct) |
View |
Ownership |
2025-05-01 5:58 pm |
N/A N/A |
Jade Biosciences Inc. | JBIO | Fairmount Funds Management LLC Fairmount Healthcare Fund II L.P. Kiselak Tomas Harwin Peter Evan Director 10% Owner |
0 | $0 | 20,777,527 (Indirect) |
View |
Ownership |
2025-05-01 5:51 pm |
N/A 2034-10-12 |
Jade Biosciences Inc. | JBIO | Lavelle Erin Director |
0 | $0 | 134,936 (Direct) |
View |
Ownership |
2025-05-01 5:44 pm |
N/A N/A |
Jade Biosciences Inc. | JBIO | Klein Lawrence Otto Director |
0 | $0 | 134,935 (Direct) |
View |
Ownership |
2025-05-01 5:39 pm |
N/A 2034-10-29 |
Jade Biosciences Inc. | JBIO | DOBMEIER ERIC Director |
0 | $0 | 269,884 (Direct) |
View |
Ownership |
2025-05-01 5:32 pm |
N/A 2034-10-29 |
Jade Biosciences Inc. | JBIO | Balta Elizabeth See Remarks |
0 | $0 | 485,782 (Direct) |
View |
Ownership |
2025-05-01 5:30 pm |
N/A 2034-10-12 |
Jade Biosciences Inc. | JBIO | Kocinsky Hetal Chief Medical Officer |
0 | $0 | 539,758 (Direct) |
View |
Ownership |
2025-05-01 5:27 pm |
N/A N/A |
Jade Biosciences Inc. | JBIO | King Andrew James See Remarks |
0 | $0 | 1,349,453 (Direct) |
View |
Ownership |
2025-05-01 5:22 pm |
N/A 2034-10-12 |
Jade Biosciences Inc. | JBIO | Quick Jonathan See Remarks |
0 | $0 | 404,818 (Direct) |
View |
Ownership |
2025-05-01 5:21 pm |
N/A 2034-10-12 |
Jade Biosciences Inc. | JBIO | Frohlich Tom Chief Executive Officer |
0 | $0 | 2,771,797 (Direct) |
View |
| 2025-04-28 Other |
2025-04-30 4:52 pm |
N/A N/A |
Jade Biosciences Inc. | JBIO | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP Kolchinsky Peter Shah Rajeev M. 10% Owner |
1,062,326 | $0 | 2,387,280 (Indirect) |
View |
| 2024-07-31 Exercise |
2024-08-02 6:00 pm |
N/A 2030-09-03 |
Aerovate Therapeutics Inc. | AVTE | Dake Benjamin T SEE REMARKS |
12,961 | $0 | 15,759 (Direct) |
View |
| 2024-07-31 Exercise |
2024-08-02 6:00 pm |
N/A N/A |
Aerovate Therapeutics Inc. | AVTE | Dake Benjamin T SEE REMARKS |
12,961 | $1.74 | 15,759 (Direct) |
View |
| 2024-06-14 Exercise |
2024-06-14 6:00 pm |
N/A 2031-04-01 |
Aerovate Therapeutics Inc. | AVTE | Eldridge George A SEE REMARKS |
15,000 | $0 | 33,785 (Direct) |
View |
| 2024-06-14 Exercise |
2024-06-14 6:00 pm |
N/A N/A |
Aerovate Therapeutics Inc. | AVTE | Eldridge George A SEE REMARKS |
15,000 | $2.14 | 33,785 (Direct) |
View |
| 2024-06-14 Exercise |
2024-06-14 6:00 pm |
N/A 2032-03-20 |
Aerovate Therapeutics Inc. | AVTE | Verwijs Marinus CHIEF TECHNICAL OFFICER |
10,600 | $0 | 68,800 (Direct) |
View |
| 2024-06-14 Exercise |
2024-06-14 6:00 pm |
N/A N/A |
Aerovate Therapeutics Inc. | AVTE | Verwijs Marinus CHIEF TECHNICAL OFFICER |
10,600 | $14.59 | 68,800 (Direct) |
View |
| 2024-06-13 Exercise |
2024-06-14 6:00 pm |
N/A 2031-04-01 |
Aerovate Therapeutics Inc. | AVTE | Gillies Hunter CHIEF MEDICAL OFFICER |
6,000 | $0 | 89,112 (Direct) |
View |
| 2024-06-13 Exercise |
2024-06-14 6:00 pm |
N/A N/A |
Aerovate Therapeutics Inc. | AVTE | Gillies Hunter CHIEF MEDICAL OFFICER |
6,000 | $2.14 | 89,112 (Direct) |
View |
| 2024-06-05 Option Award |
2024-06-07 8:29 pm |
N/A 2034-06-04 |
Aerovate Therapeutics Inc. | AVTE | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner |
12,500 | $0 | 12,500 (Indirect) |
View |
| 2024-06-05 Option Award |
2024-06-07 6:00 pm |
N/A 2034-06-04 |
Aerovate Therapeutics Inc. | AVTE | Santel Donald J Director |
12,500 | $0 | 12,500 (Direct) |
View |
| 2024-06-05 Option Award |
2024-06-07 6:00 pm |
N/A 2034-06-04 |
Aerovate Therapeutics Inc. | AVTE | Resnick Joshua Director |
12,500 | $0 | 12,500 (Direct) |
View |
| 2024-06-05 Option Award |
2024-06-07 6:00 pm |
N/A 2034-06-04 |
Aerovate Therapeutics Inc. | AVTE | Katabi Maha Director 10% Owner |
12,500 | $0 | 12,500 (Direct) |
View |
| 2024-06-05 Option Award |
2024-06-07 6:00 pm |
N/A 2034-06-04 |
Aerovate Therapeutics Inc. | AVTE | Iwicki Mark T Director |
12,500 | $0 | 12,500 (Direct) |
View |
| 2024-06-05 Option Award |
2024-06-07 6:00 pm |
N/A 2034-06-04 |
Aerovate Therapeutics Inc. | AVTE | GRAYZEL DAVID S. Director |
12,500 | $0 | 12,500 (Direct) |
View |
| 2024-06-05 Option Award |
2024-06-07 6:00 pm |
N/A 2034-06-04 |
Aerovate Therapeutics Inc. | AVTE | Dable Habib J Director |
12,500 | $0 | 12,500 (Direct) |
View |
| 2024-06-05 Option Award |
2024-06-07 6:00 pm |
N/A 2034-06-04 |
Aerovate Therapeutics Inc. | AVTE | Dorval Allison Director |
12,500 | $0 | 12,500 (Direct) |
View |
| 2024-05-17 Exercise |
2024-05-17 7:10 pm |
N/A 2031-04-01 |
Aerovate Therapeutics Inc. | AVTE | Gillies Hunter CHIEF MEDICAL OFFICER |
4,000 | $0 | 16,926 (Direct) |
View |
| 2024-05-17 Exercise |
2024-05-17 7:10 pm |
N/A N/A |
Aerovate Therapeutics Inc. | AVTE | Gillies Hunter CHIEF MEDICAL OFFICER |
4,000 | $2.14 | 16,926 (Direct) |
View |
| 2024-05-16 Exercise |
2024-05-17 7:10 pm |
N/A 2031-04-01 |
Aerovate Therapeutics Inc. | AVTE | NOYES TIMOTHY P CHIEF EXECUTIVE OFFICER |
10,000 | $0 | 343,381 (Direct) |
View |
| 2024-05-16 Exercise |
2024-05-17 7:10 pm |
N/A N/A |
Aerovate Therapeutics Inc. | AVTE | NOYES TIMOTHY P CHIEF EXECUTIVE OFFICER |
10,000 | $2.14 | 343,381 (Direct) |
View |
| 2024-05-01 Exercise |
2024-05-03 6:00 pm |
N/A 2031-04-01 |
Aerovate Therapeutics Inc. | AVTE | NOYES TIMOTHY P CHIEF EXECUTIVE OFFICER |
10,000 | $0 | 353,381 (Direct) |
View |
| 2024-05-01 Exercise |
2024-05-03 6:00 pm |
N/A N/A |
Aerovate Therapeutics Inc. | AVTE | NOYES TIMOTHY P CHIEF EXECUTIVE OFFICER |
10,000 | $2.14 | 353,381 (Direct) |
View |
| 2024-04-17 Exercise |
2024-04-19 6:00 pm |
N/A 2031-04-01 |
Aerovate Therapeutics Inc. | AVTE | Dake Benjamin T SEE REMARKS |
6,853 | $0 | 97,227 (Direct) |
View |
| 2024-04-17 Exercise |
2024-04-19 6:00 pm |
N/A N/A |
Aerovate Therapeutics Inc. | AVTE | Dake Benjamin T SEE REMARKS |
6,853 | $2.14 | 97,227 (Direct) |
View |
| 2024-04-17 Exercise |
2024-04-19 6:00 pm |
N/A 2030-09-03 |
Aerovate Therapeutics Inc. | AVTE | Gillies Hunter CHIEF MEDICAL OFFICER |
4,000 | $0 | 6,301 (Direct) |
View |
| 2024-04-17 Exercise |
2024-04-19 6:00 pm |
N/A N/A |
Aerovate Therapeutics Inc. | AVTE | Gillies Hunter CHIEF MEDICAL OFFICER |
4,000 | $1.74 | 6,301 (Direct) |
View |
| 2024-04-16 Exercise |
2024-04-18 6:00 pm |
N/A 2031-04-01 |
Aerovate Therapeutics Inc. | AVTE | NOYES TIMOTHY P CHIEF EXECUTIVE OFFICER |
10,000 | $0 | 363,381 (Direct) |
View |
| 2024-04-16 Exercise |
2024-04-18 6:00 pm |
N/A N/A |
Aerovate Therapeutics Inc. | AVTE | NOYES TIMOTHY P CHIEF EXECUTIVE OFFICER |
10,000 | $2.14 | 363,381 (Direct) |
View |
| 2024-04-10 Exercise |
2024-04-12 6:00 pm |
N/A 2031-04-01 |
Aerovate Therapeutics Inc. | AVTE | Eldridge George A SEE REMARKS |
7,500 | $0 | 45,723 (Direct) |
View |
| 2024-04-10 Exercise |
2024-04-12 6:00 pm |
N/A N/A |
Aerovate Therapeutics Inc. | AVTE | Eldridge George A SEE REMARKS |
7,500 | $2.14 | 45,723 (Direct) |
View |